Catawba Capital Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$1.23M Buy
17,515
+1,922
+12% +$138K 0.29% 79
2018
Q1
$1.09M Sell
15,593
-90
-0.6% -$6.23K 0.26% 83
2017
Q4
$1.09M Hold
15,683
0.25% 86
2017
Q3
$1.06M Sell
15,683
-220
-1% -$13.9K 0.24% 91
2017
Q2
$1.08M Buy
15,903
+28
+0.2% +$1.83K 0.25% 91
2017
Q1
$989K Sell
15,875
-2,520
-14% -$147K 0.22% 106
2016
Q4
$1M Sell
18,395
-38
-0.2% -$2.16K 0.23% 106
2016
Q3
$1.21M Buy
18,433
+563
+3% +$36.8K 0.29% 89
2016
Q2
$1.08M Hold
17,870
0.26% 95
2016
Q1
$1.01M Sell
17,870
-1,400
-7% -$84.1K 0.26% 96
2015
Q4
$1.31M Sell
19,270
-315
-2% -$20.7K 0.36% 76
2015
Q3
$1.25M Buy
19,585
+2,430
+14% +$160K 0.34% 76
2015
Q2
$1.09M Hold
17,155
0.26% 91
2015
Q1
$1.17M Buy
17,155
+425
+3% +$29.5K 0.27% 89
2014
Q4
$1.18M Sell
16,730
-150
-0.9% -$10.7K 0.27% 90
2014
Q3
$1.21M Hold
16,880
0.28% 88
2014
Q2
$1.25M Sell
16,880
-75
-0.4% -$5.42K 0.28% 91
2014
Q1
$1.1M Sell
16,955
-2,130
-11% -$138K 0.26% 93
2013
Q4
$1.13M Buy
19,085
+3,545
+23% +$193K 0.27% 90
2013
Q3
$807K Buy
+15,540
New +$781K 0.21% 104

Other funds holding AZN